OmniAb, Inc. (OABI)
4.35
-0.57
(-11.59%)
USD |
NASDAQ |
Oct 06, 16:00
4.35
0.00 (0.00%)
After-Hours: 20:00
OmniAb Net Income (Quarterly) : -5.859M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -5.859M |
| March 31, 2026 | -7.707M |
| December 31, 2025 | -14.18M |
| September 30, 2025 | -16.52M |
| June 30, 2025 | -15.88M |
| March 31, 2025 | -18.20M |
| December 31, 2024 | -13.07M |
| September 30, 2024 | -16.37M |
| June 30, 2024 | -13.63M |
| March 31, 2024 | -18.96M |
| December 31, 2023 | -14.05M |
| Date | Value |
|---|---|
| September 30, 2023 | -15.74M |
| June 30, 2023 | -14.73M |
| March 31, 2023 | -6.10M |
| December 31, 2022 | 6.82M |
| September 30, 2022 | -12.60M |
| June 30, 2022 | -10.28M |
| March 31, 2022 | -6.282M |
| December 31, 2021 | -3.072M |
| September 30, 2021 | -0.1706M |
| June 30, 2021 | -0.0022M |
| March 31, 2021 | -0.0078M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| IQVIA Holdings, Inc. | 258.00M |
| Champions Oncology, Inc. | -0.426M |
| Medpace Holdings, Inc. | 121.36M |
| Charles River Laboratories International, Inc. | -0.76M |
| Avantor, Inc. | 38.10M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 13.42M |
| Total Expenses (Quarterly) | 19.27M |
| EPS Diluted (Quarterly) | -0.0455 |
| Enterprise Value | 599.37M |
| Gross Profit Margin (Quarterly) | 64.01% |
| Profit Margin (Quarterly) | -43.68% |
| Earnings Yield | -8.29% |
| Normalized Earnings Yield | -8.393 |